The average selling price for QED in New Zealand dropped in 2022, according to GlobalData. The average selling price, the complete price range of high and low prices and a 3-year forecast for the QED device in New Zealand can be viewed in GlobalData’s micro pricing report. Buy the report here.
The QED is sold by Orasure Technologies in the Toxicology Tests market. Toxicology Tests are in vitro diagnostic devices that measure toxic substances or drugs in patient samples, such as blood and urine. These devices measure a wide range of different substances such as barbiturates, cannabinoids, depressants hallucinogens, narcotics, and stimulants.
Factors contributing to the list price of a medical device include but are not limited to therapy area, complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. Moreover, final selling prices vary geographically and by facility type. These prices are further subject to discounts, as well as purchasing and distribution agreements.
For a complete picture of Orasure Technologies’ Toxicology Tests device pricing in New Zealand, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.